• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Just announced on Merck Board!

























This IDIOT is a complete MORON!! HE/SHE has no clue on patent litigation and how long it takes to settle such disputes. Statue 102.3 of the US FEDERAL PATENT LAW clearly states that a "right to claim" cannot fully be exercised until their is extensive research into existent/non-existent equitable violations based upon years of internal processes upon both the suitor and the holder of such patents in question. THEREFORE, this will NOT be realized for years to come.